Membrane anchored immunostimulatory oligonucleotides for in vivo cell modification and localized immunotherapy.
about
Improving the clinical impact of biomaterials in cancer immunotherapy.Structure-based programming of lymph-node targeting in molecular vaccines.Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccineRhamnose glycoconjugates for the recruitment of endogenous anti-carbohydrate antibodies to tumor cells.Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation.Directing the assembly of spatially organized multicomponent tissues from the bottom up.DNA-inorganic hybrid nanovaccine for cancer immunotherapySelf-Assembled DNA Immunonanoflowers as Multivalent CpG Nanoagents.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Biomaterials for enhancing anti-cancer immunity.Delivering safer immunotherapies for cancer.In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity.Light Guided In-vivo Activation of Innate Immune Cells with Photocaged TLR 2/6 Agonist.Efficient targeting of fatty-acid modified oligonucleotides to live cell membranes through stepwise assembly.Aminated nanomicelles as a designer vaccine adjuvant to trigger inflammasomes and multiple arms of the innate immune response in lymph nodes.Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.Immunoengineering with biomaterials for enhanced cancer immunotherapy.Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.DNA probes for monitoring dynamic and transient molecular encounters on live cell membranes.Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in Mouse Brain.Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.Polyvalent Display of Biomolecules on Live Cells.A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy.In vitro and in vivo supramolecular modification of biomembranes using a lipidated coiled-coil motif.Performing DNA nanotechnology operations on a zebrafishImaging plasma membranes without cellular internalization: multisite membrane anchoring reagents based on glycol chitosan derivatives
P2860
Q26766267-8B99B66C-9A1E-4290-9EF5-7C2F5760ED29Q33800766-BD933B32-FC8B-464C-B77A-A913576BC503Q34157315-6CB83CCA-278C-4EB2-B6BF-20118BC0336EQ34380952-110A297A-7EAD-4E9E-8018-969D1CA77CC1Q35447388-88912655-8535-493B-BFA8-CA739D2C9AFFQ36420075-DEB77123-FB6D-4B5B-87DA-6B8937261420Q36727767-B367020F-72A3-43D5-BFB2-A8722109B5EFQ36981879-2EAFF7AE-9EB7-4F04-9ADF-9E628FA2F77FQ38677432-25609221-B5F0-4AA0-913C-6B608E18B442Q38741829-92ED243B-6E13-42AE-B28A-0C1FE73519C8Q39330984-B619E67B-A275-4BA2-B9D0-D62475A53A3BQ40937108-9154CA3E-3E84-4730-89BE-6FD97F361645Q41388766-6F85ED98-39D5-4C5A-87A9-C906D7AE59D5Q42157617-487632FA-52CF-4D61-A265-6F31F34DD180Q42656447-BDACBD6E-82D1-4EC8-BAF4-2045F96877B4Q46205951-6EE12B51-61C8-456F-8EDB-501FE31A6C27Q47342244-28AC13E4-AA08-4CBB-8470-7E9DC38FC123Q47732542-B5D20DAE-82F2-4455-9C37-392CCB01C6F9Q47738496-8585C44E-250F-49DD-9CBC-6D272DB7CD7DQ47923667-42F82109-0639-4B01-9DFD-21CA41980FA2Q48208830-13B63D81-8870-4BCC-B1B6-2D6708A214DAQ48504870-5A24A238-B814-4AAA-BF9F-A1B56C18305FQ49586288-2148B4F1-99A0-4650-B012-44DAE06D03B6Q50072990-C4086A0C-1CCA-4489-948F-72D317CB80DBQ54626815-D754CCA7-BCB3-47A5-95D8-5A2630F43C70Q57139031-03357FC2-18F9-4BDC-BC52-A8622B86AB51Q57974285-698B3173-67D5-4958-80A3-A158FCCCC62A
P2860
Membrane anchored immunostimulatory oligonucleotides for in vivo cell modification and localized immunotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Membrane anchored immunostimul ...... n and localized immunotherapy.
@en
type
label
Membrane anchored immunostimul ...... n and localized immunotherapy.
@en
prefLabel
Membrane anchored immunostimul ...... n and localized immunotherapy.
@en
P2093
P2860
P356
P1476
Membrane anchored immunostimul ...... n and localized immunotherapy.
@en
P2093
Brandon Kwong
Darrell J Irvine
Haipeng Liu
P2860
P304
P356
10.1002/ANIE.201101266
P407
P577
2011-06-17T00:00:00Z